Quantbot Technologies LP Cellectis S.A. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$18.19 - $33.25 $52,751 - $96,425	-2,900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.87 - $31.64 $46,023 - $91,756	2,900 New	2,900 $78,000
Q4 2018 Feb 13, 2019	SELL	$15.58 - $28.41 $54,966 - $100,230	-3,528 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$25.99 - $30.6 $79,945 - $94,125	3,076 Added 680.53%	3,528 $99,000
Q2 2018 Aug 13, 2018	SELL	$27.78 - $38.53 $102,452 - $142,098	-3,688 Reduced 89.08%	452 $12,000
Q1 2018 May 11, 2018	BUY	$27.78 - $35.19 $115,009 - $145,686	4,140 New	4,140 $130,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $86M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.